CASP9 and breast carcinoma: Importantly, the MTT test for cytotoxicity and the ELISA activity of caspase-3, caspase-9, and p53 in comparison to free DSM or a control were used to assess the potential cytotoxicity of D-NSP3 on the MCF-7 breast cancer cell line.